TrialHealth technology assessment (Winchester, England)2024

Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT.

Miriam Santer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.